Inherited Cancer - Clinical Oncology Next Generation Sequencing Market
The global inherited cancer clinical oncology next generation sequencing market size was valued at US$ 130.8 million in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 16.5% from 2022 to 2030.